跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,280 条关于
“Atezo/Bev”
全部
3,280
临床试验
2,377
药物
416
机构
195
资讯
292
去年
Anti-PD-1 Autoantibody Levels Predict Survival in Liver Cancer Patients Treated with Atezolizumab and Bevacizumab
去年
Phase 1 Trial of Zanza-Atezo Combo Shows Early Promise in Colorectal Cancer, But Questions Remain
去年
Taiho Oncology to Present Real-World Data on Colorectal Cancer Treatments at ASCO GI 2025
去年
Australian Companies Form Strategic Alliance to Boost Advanced Therapy Manufacturing Capacity
去年
Panavance Therapeutics Prepares IND Submission for Misetionamide in Ovarian Cancer
去年
Cardiff Oncology Secures Second Patent for Onvansertib in Bevacizumab-Naïve mCRC Patients
去年
EL1SSAR Trial Confirms Efficacy of Atezolizumab Plus Nab-Paclitaxel in PD-L1-Positive Advanced TNBC
3个月前
Greater Manchester Secures £50M UKRI Innovation Funding, Backing Health Data, Wearables and AI-Driven Life Sciences Projects
3个月前
VT-EBV-N Shows 95% Durable Disease-Free Survival in EBV-Positive ENKTL: Phase II Data at EHA 2026
2年前
FDA Grants Priority Review to Tabelecleucel for EBV+ PTLD Treatment
第 1 页,共 30 页
上一页
下一页